来自:中国糖尿病杂志 编辑:朱云霞 钟远|点击数:|2016-04-25
【提要】 分泌型卷曲相关蛋白5(SFRP5)是新发现的脂肪因子,可通过抗炎机制改善IR。对肥胖和T2DM患者进行药物或生活方式干预可提高血循环SFRP5水平,改善IS。 SFRP5或可成为肥胖和T2DM新的治疗靶点。
【关键词】 分泌型卷曲相关蛋白5;脂肪因子;胰岛素抵抗;代谢性疾病
The progression of the research on SFRP5 and obesity and related metabolic diseases ZHU Yun-xia, ZHONG Yuan, Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
Corresponding author: ZHONG Yuan, E-mail:zhyy_666@163.com
【Summary】 Secreted frizzled-related protein 5 is a novel adipokine, which has been shown to improve insulin resistance by inhibiting inflammation. Anti-diabetes drugs and lifestyle interventions have been reported to improve insulin resistance and increase circulating SFRP5 level in subjects with type 2 diabetes (T2DM) and obesity. SFRP5 may become the new therapeutic target.
【Key words】Secreted frizzled-related protein 5; Adipokine; Insulin resistance; Metabolic diseases
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想